Sever Elif Arik, Aybakan Esma, Beşli Yeşim, Karatuna Onur, Kocagoz Tanil
Department of Medical Biotechnology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
Department of Biostatistics and Bioinformatics, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
Front Microbiol. 2024 Feb 9;15:1357680. doi: 10.3389/fmicb.2024.1357680. eCollection 2024.
Standard, phenotypic antimicrobial susceptibility testing (AST) methods require 16-20 h of incubation and are considered as the bottleneck in providing timely input for appropriate antimicrobial treatment. In this study, a novel adenosine triphosphate (ATP)-bioluminescence-based method which allows rapid AST within 3 h was described.
Standard AST was performed for 56 isolates using EUCAST disk diffusion (DD) methodology. For the bioluminescence-based rapid AST, suspensions of bacteria were prepared using Mueller-Hinton broth to obtain a turbidity of 0.5 McFarland. The suspensions were distributed into 96-well microtiter plates. ATP (20 mM) and fixed concentrations of different antibiotics were added. Following incubation at 37°C for 1 h, a luminescent reaction mixture, including the substrate luciferin and luciferase enzyme solutions, was added. The chemiluminescence was monitored using an imaging system. Light production demonstrated the presence of ATP, indicating that the isolate was susceptible to the antibiotic in the well. Absence or decrease of light intensity, compared with the growth control well, indicated the use of ATP as an indirect measure of bacterial growth, and therefore resistance to the antibiotic in the well.
The novel AST method was tested using a total of 348 test wells. Concordance was achieved for 290 (83.3%) of the tests, whereas 52 (14.9%) and 6 (1.7%) tests caused minor and major errors, respectively.
In this study, a bioluminescence-based rapid AST was developed based on the consumption of ATP by bacteria. Our method's uniqueness relies on determining ATP consumption by microorganisms in the presence or absence of an antibiotic. The novel AST method described in this study lays the groundwork for obtaining rapid results, which should be considered as a proof of concept. With further optimization studies, this novel method can provide higher accuracy and be introduced into clinical practice as a routine AST method.
标准的表型抗菌药物敏感性试验(AST)方法需要16 - 20小时的孵育时间,被认为是为适当的抗菌治疗及时提供信息的瓶颈。在本研究中,描述了一种基于三磷酸腺苷(ATP)生物发光的新方法,该方法可在3小时内完成快速AST。
使用欧洲抗菌药物敏感性试验委员会(EUCAST)纸片扩散(DD)法对56株分离菌进行标准AST。对于基于生物发光的快速AST,用Mueller - Hinton肉汤制备细菌悬液,使其浊度达到0.5麦氏单位。将悬液分装到96孔微量滴定板中。加入ATP(20 mM)和固定浓度的不同抗生素。在37°C孵育1小时后,加入包括底物荧光素和荧光素酶溶液的发光反应混合物。使用成像系统监测化学发光。发光表明存在ATP,表明分离菌对孔中的抗生素敏感。与生长对照孔相比,光强度的缺失或降低表明使用ATP作为细菌生长的间接指标,因此表明对孔中的抗生素耐药。
共使用348个测试孔对这种新的AST方法进行了测试。290次(83.3%)测试结果一致,而分别有52次(14.9%)和6次(1.7%)测试出现轻微和重大误差。
在本研究中,基于细菌对ATP的消耗开发了一种基于生物发光的快速AST。我们方法的独特之处在于确定在有或没有抗生素的情况下微生物对ATP的消耗。本研究中描述的新AST方法为获得快速结果奠定了基础,应被视为一种概念验证。通过进一步的优化研究,这种新方法可以提供更高的准确性,并作为常规AST方法引入临床实践。